Considerable Heterogeneity
- PMID: 29563008
- PMCID: PMC5876544
- DOI: 10.3238/arztebl.2018.0143a
Considerable Heterogeneity
Comment in
-
In Reply.Dtsch Arztebl Int. 2018 Mar 2;115(9):143-144. doi: 10.3238/arztebl.2018.0143b. Dtsch Arztebl Int. 2018. PMID: 29563009 Free PMC article. No abstract available.
Comment on
-
Cannabinoids in Pain Management and Palliative Medicine.Dtsch Arztebl Int. 2017 Sep 22;114(38):627-634. doi: 10.3238/arztebl.2017.0627. Dtsch Arztebl Int. 2017. PMID: 29017688 Free PMC article.
References
-
- Zajicek J, Fox P, Sanders H, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicenter randomized placebo-controlled trial. Lancet. 2003;362:1517–1526. - PubMed
-
- National Academies of Sciences, Engineering, and Medicine. The National Academies Press 2017. doi: 10.17226/24625. Washington, DC: The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources